‘NK Cells’
Computational Simulations of Bispecific Aptamers Targeting CD16+ Natural Killer Cells and PD-L1+ Cancer Cells
A computational study exploring the design of bispecific aptamers to enhance NK cell-mediated cancer therapy through targeted receptor interactions.
Posted by buchanle on Friday, June 20th, 2025 in May 2025, Aptamer, CAR T-cell Therapy, Molecular Docking, NK Cells